Meeting: 38th U.S.-Japan Council Business Advisory Board Meeting

2026.01.22

SCIENCE

Provigate, Inc. will have its CEO, Koshin Sekimizu, speak at the 38th U.S.-Japan Council Business Advisory Board Meeting, to be held on Thursday, January 29, 2026, at the Tokyo American Club in Tokyo, Japan.
The Business Advisory Board (BAB) provides a platform based in Japan that brings together business leaders from diverse fields—including government, academia, and the non-profit sector—to expand people-to-people connections and strengthen ties between the United States and Japan.
At this meeting, Mr. Sekimizu will share insights from our latest device development and clinical research, and offer a vision for the future of healthcare—where behavioral science and technology come together to break stigma and enable proactive diabetes care.
Please note that this event is organized as a meeting for invited participants.

Event Name
38th U.S.-Japan Council Business Advisory Board Meeting

Date & Venue
January 29 (Thu), 2026
Tokyo American Club, Tokyo, Japan

For more details, please refer to the official website.
https://www.usjapancouncil.org/events/38th-usjc-business-advisory-board-meeting/

People may think of glucose monitoring as simple as this: "Diabetes is a disease of blood sugar. This is why people with diabetes use glucometer."
However, it's not that simple. Blood sugar measurement has diverse objectives, including diagnosing diabetes, dosing self-injection of insulin, avoiding hypoglycemia due to excessive drug efficacy, and behavior change.
You must choose the appropriate blood sugar measurement method for your purpose.

There are two types of self-blood glucose measurement methods: SMBG (Self-Monitoring of Blood Glucose), which is widely used, and CGM (Continuous Glucose Monitoring), which has become popular in recent years.
These two blood glucose measurement methods are designed mainly for patients who self-inject insulin and other injectable drugs.
Until now, there has been no simple and daily method for measuring blood glucose at home other than these two methods.

Some drugs, such as insulin, are very potent and can cause dangerous hypoglycemia if the dosage is incorrect.
Therefore, for example, those who use insulin must measure their blood glucose accurately before self-injection at home and carefully determine the dose.
After injection, if there are signs of hypoglycemia, it is necessary to measure blood glucose immediately. If necessary, you need to take some sugar to avoid hypoglycemia.
However, both methods have an issue with invasiveness. In addition, they cost a lot. CGM costs at least $60 and needs to be replaced every two weeks, which is also a significant economic burden. SMBG requires frequent measurements, so the total cost becomes significant when accumulated.
Unfortunately, SMBG and CGM are not suitable for everyone due to invasiveness and cost.